BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26588458)

  • 1. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
    Lafay-Cousin L; Lindzon G; Taylor MD; Hader W; Hawkins C; Nordal R; Laperriere N; Laughlin S; Bouffet E; Bartels U
    J Neurosurg Pediatr; 2016 Mar; 17(3):298-302. PubMed ID: 26588458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
    Lafay-Cousin L; Mabbott DJ; Halliday W; Taylor MD; Tabori U; Kamaly-Asl ID; Kulkarni AV; Bartels U; Greenberg M; Bouffet E
    J Neurosurg Pediatr; 2010 Jun; 5(6):615-21. PubMed ID: 20515336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
    Sawamura Y; Shirato H; Ikeda J; Tada M; Ishii N; Kato T; Abe H; Fujieda K
    J Neurosurg; 1998 Jan; 88(1):66-72. PubMed ID: 9420074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
    Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
    Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
    López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E
    Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
    Kushner BH; Modak S; Kramer K; Basu EM; Roberts SS; Cheung NK
    Cancer; 2013 Feb; 119(3):665-71. PubMed ID: 22951749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas.
    Schneider C; Kamaly-Asl I; Ramaswamy V; Lafay-Cousin L; Kulkarni AV; Rutka JT; Remke M; Coluccia D; Tabori U; Hawkins C; Bouffet E; Taylor MD
    J Neurosurg Pediatr; 2015 Aug; 16(2):126-33. PubMed ID: 25932777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
    Oberlin O; Rey A; Sanchez de Toledo J; Martelli H; Jenney ME; Scopinaro M; Bergeron C; Merks JH; Bouvet N; Ellershaw C; Kelsey A; Spooner D; Stevens MC
    J Clin Oncol; 2012 Jul; 30(20):2457-65. PubMed ID: 22665534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric choroid plexus neoplasms.
    Chow E; Reardon DA; Shah AB; Jenkins JJ; Langston J; Heideman RL; Sanford RA; Kun LE; Merchant TE
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):249-54. PubMed ID: 10760416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.
    Jordan K; Wolf HH; Voigt W; Kegel T; Mueller LP; Behlendorf T; Sippel C; Arnold D; Schmoll HJ
    Bone Marrow Transplant; 2010 Dec; 45(12):1704-9. PubMed ID: 20228848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.